Dr. Joselin D. Tacastacas, MD

Dr. Tacastacas practices at Dermatology Specialists in Newport News, Virginia.

Dr. Tacastacas' NPI, 1184673295, was assigned on May 8, 2006. Dr. Tacastacas holds Virginia license 0101236219.

Dr. Tacastacas' primary practice is Dermatology Specialists, at 11844 Rock Landing Dr, Newport News, VA 23606 in Newport News City. The practice phone is (757) 873-0161.

Dr. Tacastacas' primary practice is Dermatology Specialists in Newport News, Virginia. The medical group on file is Peninsula Dermatology Skin Cancer Surgery Center. Dmand AI also links Dr. Tacastacas to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tacastacas practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Tacastacas' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Tacastacas' licenses on file in 2 states: Virginia and Oregon.

CMS data shows 4,635 Medicare services from Dr. Tacastacas across 17 procedure codes in 2024, for 1,024 Medicare patients. Medicare paid $230,638 for them. Every service was in an office.

CMS counts 1,024 Medicare patients who saw Dr. Tacastacas in 2024. The largest group is 65 to 74, with 477 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tacastacas' median patient age at 72, with 66% women.

In 2024, Dr. Tacastacas wrote 593 Medicare Part D claims for 287 patients. 92% of them were for generic drugs. CMS names the drug for 484 of them, across 13 drugs with 11 or more claims each, at $140,905 in total drug cost. In 2023, CMS named 729 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tacastacas for performance year 2024, reported as part of a group. Dr. Tacastacas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 825 procedures of skin biopsy by Dr. Tacastacas, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Tacastacas, published from 2014 to 2022. The most frequent topics are Lymphoma, T-Cell, Cutaneous, Psoriasis and Skin Neoplasms. Dr. Tacastacas' most frequent co-authors are Kord S. Honda, MD, Derek Victor Chan, MD, PhD and Yoon K. Cohen, DO.

CMS Open Payments shows 250 general payments to Dr. Tacastacas from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $1,025.